Tandem Diabetes Care, Inc.
TNDM
$19.12
$0.9355.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 282.65M | 243.97M | 221.91M | 191.67M | 196.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 282.65M | 243.97M | 221.91M | 191.67M | 196.80M |
| Cost of Revenue | 125.19M | 119.32M | 109.12M | 97.00M | 103.50M |
| Gross Profit | 157.46M | 124.65M | 112.79M | 94.67M | 93.30M |
| SG&A Expenses | 105.84M | 99.64M | 94.24M | 90.11M | 87.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 283.23M | 270.06M | 252.68M | 233.35M | 233.96M |
| Operating Income | -582.00K | -26.09M | -30.77M | -41.68M | -37.16M |
| Income Before Tax | 16.00K | -22.61M | -29.74M | -39.53M | -31.31M |
| Income Tax Expenses | -739.00K | 637.00K | 1.07M | 3.19M | -1.31M |
| Earnings from Continuing Operations | 755.00K | -23.25M | -30.81M | -42.72M | -30.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 755.00K | -23.25M | -30.81M | -42.72M | -30.00M |
| EBIT | -582.00K | -26.09M | -30.77M | -41.68M | -37.16M |
| EBITDA | 3.66M | -21.88M | -26.67M | -37.64M | -33.13M |
| EPS Basic | 0.01 | -0.35 | -0.47 | -0.65 | -0.46 |
| Normalized Basic EPS | 0.02 | -0.22 | -0.27 | -0.37 | -0.32 |
| EPS Diluted | 0.01 | -0.35 | -0.47 | -0.65 | -0.46 |
| Normalized Diluted EPS | 0.02 | -0.22 | -0.27 | -0.37 | -0.32 |
| Average Basic Shares Outstanding | 65.94M | 65.54M | 64.99M | 65.33M | 65.37M |
| Average Diluted Shares Outstanding | 66.16M | 65.54M | 64.99M | 65.33M | 65.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
